Mostrar el registro sencillo del ítem

dc.contributor.authorGarcía-Serrano, José Luis 
dc.contributor.authorProtsyk, Olena
dc.contributor.authorDomech Serrano, Teresa
dc.contributor.authorUberos Fernández, José 
dc.date.accessioned2025-01-07T12:03:15Z
dc.date.available2025-01-07T12:03:15Z
dc.date.issued2025-01-07
dc.identifier.citationGarcía Serrano, J.L. et. al. J. Clin. Med. 2025, 14, 297 [https://doi.org/10.3390/jcm14020297]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/98518
dc.description.abstractBackground: We sought to develop a structural equation model (SEM) identifying physical and clinical risk factors associated with treatment for retinopathy of prematurity (ROP). Methods: This retrospective, observational, case–control study included 314 infants screened for ROP between April 2004 and July 2024. A bivariate binary logistic regression model, decision tree, and structural equation model (SEM) were employed to develop a more general model for ROP requiring treatment. Results: In the SEM, the factors significantly associated with ROP treatment included the retinal avascular area according to disk diameter (DD) (p < 0.001), weekly vascularisation rate (DD/w) (p < 0.001), and duration of intubation (days) (p < 0.001). In addition, the following significant associations were identified in both the bivariate analysis and the SEM: lower gestational age (p < 0.001) and birth weight (p <0.001) were associated with greater retinal avascular area; low postnatal weight gain (p < 0.027) was associated with a slow rate of retinal vascularisation; sepsis (p < 0.001), ductus arteriosus (p < 0.001), and the need for transfusion (p < 0.001) were associated with longer intubation mechanical ventilation (IMV). Conclusions: Lower gestational age, lower birth weight, sepsis, ductus arteriosus, transfusion, and lower weight gain increase the risk of requiring ROP treatment. In the SEM, this association is represented through three intermediate physical endogenous variables, namely, the greater temporal avascular area of the retina, the lower postnatal vascularisation rate, and the greater duration of IMV.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectretinopathy of prematurityes_ES
dc.subjecttherapyes_ES
dc.subjectstructural equation modelses_ES
dc.titleStructural Equation Modelling of Retinopathy of Prematurity Treatment Integrating Both Physical and Clinical Effectses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/jcm14020297
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional